PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
17.10
-0.15 (-0.87%)
Mar 4, 2026, 10:12 AM EST - Market open
PureTech Health Revenue
PureTech Health had revenue of $925.50K in the half year ending June 30, 2025, with 542.71% growth. This brings the company's revenue in the last twelve months to $6.39M, up 1,265.60% year-over-year. In the year 2024, PureTech Health had annual revenue of $4.83M with 44.98% growth.
Revenue (ttm)
$6.39M
Revenue Growth
+1,265.60%
P/S Ratio
62.25
Revenue / Employee
$114,125
Employees
56
Market Cap
397.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.83M | 1.50M | 44.98% |
| Dec 31, 2023 | 3.33M | -12.29M | -78.68% |
| Dec 31, 2022 | 15.62M | -1.77M | -10.18% |
| Dec 31, 2021 | 17.39M | 5.62M | 47.76% |
| Dec 31, 2020 | 11.77M | 1.96M | 20.00% |
| Dec 31, 2019 | 9.81M | -10.94M | -52.73% |
| Dec 31, 2018 | 20.75M | 18.21M | 718.46% |
| Dec 31, 2017 | 2.54M | -1.90M | -42.79% |
| Dec 31, 2016 | 4.43M | -7.40M | -62.54% |
| Dec 31, 2015 | 11.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 170.16M |
| Niagen Bioscience | 124.71M |
| Century Therapeutics | 113.34M |
| Bicycle Therapeutics | 28.34M |
| Immutep | 5.28M |
| Armata Pharmaceuticals | 5.05M |
| Upstream Bio | 2.80M |
PRTC News
- 7 days ago - PureTech to Present at the Leerink Partners Global Healthcare Conference - Business Wire
- 13 days ago - PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis - Business Wire
- 6 weeks ago - PureTech Health PLC at JPMorgan Healthcare Conference Transcript - GuruFocus
- 6 weeks ago - PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - PureTech Health (PRTC) Appoints Robert Lyne as CEO - GuruFocus
- 2 months ago - PureTech Health Appoints Robert Lyne As CEO; Focuses On Financing For Celea, Gallop Oncology - Nasdaq
- 2 months ago - PureTech Appoints Robert Lyne as Chief Executive Officer - Business Wire